BMP6 Antikörper (N-Term)
Kurzübersicht für BMP6 Antikörper (N-Term) (ABIN929061)
Target
Alle BMP6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- BMP6 antibody was raised in rabbit using the N terminal of BMP6 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BMP6 Blocking Peptide, (ABIN937336), is also available for use as a blocking control in assays to test for specificity of this BMP6 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BMP6 (Bone Morphogenetic Protein 6 (BMP6))
-
Andere Bezeichnung
- BMP6
-
Hintergrund
- The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, the BMP encoded by this gene has a proposed role in early development. In addition, the fact that this BMP is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity. Synonyms: Polyclonal BMP6 antibody, Anti-BMP6 antibody, bone morphogenetic protein 6 antibody, VGR antibody, VGR1 antibody.
-
Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process
Target
-